Investors searching for an Ares Capital stock price target are gravitating toward $23 because it sits at a meaningful intersection: it matches the highest analyst price target currently published, and it rests just above the stock's 52-week high of $22.51. Reaching $23 would therefore mark not just a roughly 15% advance from recent prices, but a decisive breakout into territory ARCC has not traded in over the past year.
Ares Capital Corporation is a Business Development Company, or BDC — a specialized public company that lends to, and sometimes invests in, private middle-market businesses. ARCC is the largest BDC in the United States, providing first-lien senior secured loans, second-lien loans, mezzanine debt, and equity financing to companies typically generating between $10 million and $250 million in EBITDA (earnings before interest, taxes, depreciation, and amortization). BDCs must distribute most of their taxable income to shareholders, which is why ARCC carries a dividend yield near 9.6% on an annualized payout of about $1.92 per share.
ARCC trades around $19.91 with a market capitalization near $14.3 billion. The shares sit well above their 52-week low of $17.40 but roughly 11% below the $22.51 high. With a price-to-earnings (P/E) ratio in the mid-teens on a trailing basis, the stock reflects the market's confidence in its durable income stream, though its valuation has drawn attention from analysts who note it trades at a premium to its own historical multiple.
Several factors support a move toward $23. First, ARCC's scale and its relationship with parent Ares Management give it deep origination capabilities and access to capital, including recently expanded revolving credit facilities. Second, its portfolio is broadly diversified across sectors such as healthcare, software, and business services, reducing single-company concentration risk. Third, a more stable or lower interest-rate environment could ease borrowing costs and stimulate the M&A and refinancing activity that fuels new loan origination — a key driver of BDC earnings growth.
The path to $23 is not without friction. BDCs borrow to fund their lending, so higher funding costs can compress net interest margins and net operating income. A prolonged slowdown in M&A and private-equity deal activity would also limit new investment opportunities. Additionally, analysts have flagged the risk of continued non-accruals and restructurings, which could pressure earnings and dividend coverage into next year. Wells Fargo, for example, downgraded ARCC to Equal Weight in June 2026, citing "richer valuations" and a challenging environment for the sector.
Wall Street remains broadly constructive, with a consensus "Buy" rating and roughly 11 buy ratings against three holds and no sells among covering analysts. The average analyst price target sits near $20.62, while estimates span from $19 to a high of $23. That dispersion is telling: even bullish analysts expect only modest near-term upside, and the $23 figure represents the optimistic end of the range rather than a base case. Several firms — including Truist, KBW, and JPMorgan — trimmed targets in 2026, signaling tempered confidence rather than outright bearishness.
From a technical analysis standpoint, $17.40 to $18.50 has functioned as a support area, absorbing selling pressure earlier in the year. On the upside, $22.50 to $23 forms a clear supply zone defined by the 52-week high and the consensus-high analyst target. A sustained push through $23 would signal that buyers have absorbed overhead supply and could open the door to further gains; failure near that resistance level would keep ARCC range-bound.
Traders seeking an edge in timing entries and exits can look to Tickeron's AI Daily Buy/Sell Signals. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. By surfacing these signals automatically, the product helps traders discover new opportunities, track existing positions, and identify shifting market trends more efficiently than manual screening alone.
Reaching $23 is realistic but far from guaranteed. The strongest case rests on ARCC's scale, its attractive dividend yield, and a diversified portfolio that could benefit from a more favorable financing backdrop. The primary risks are persistent funding-cost pressure, weak deal flow, and deteriorating credit quality that could erode earnings. For now, $23 appears to be an achievable long-term objective rather than a near-term certainty. Investors should monitor interest-rate trends, portfolio non-accrual levels, origination volume, and whether ARCC can reclaim and hold the $22.50 area before challenging the $23 mark.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, ARCC has been closely correlated with OBDC. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARCC jumps, then OBDC could also see price increases.
| Ticker / NAME | Correlation To ARCC | 1D Price Change % | ||
|---|---|---|---|---|
| ARCC | 100% | -1.27% | ||
| OBDC - ARCC | 80% Closely correlated | -1.59% | ||
| GBDC - ARCC | 78% Closely correlated | -1.49% | ||
| BXSL - ARCC | 76% Closely correlated | -1.90% | ||
| NMFC - ARCC | 72% Closely correlated | -1.96% | ||
| MAIN - ARCC | 72% Closely correlated | -1.47% | ||
More | ||||